Two Sigma Advisers LP Reduces Stock Holdings in CBIZ, Inc. (NYSE:CBZ)

Two Sigma Advisers LP trimmed its stake in CBIZ, Inc. (NYSE:CBZ - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 92,023 shares of the business services provider's stock after selling 6,800 shares during the period. Two Sigma Advisers LP owned approximately 0.18% of CBIZ worth $7,530,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Smartleaf Asset Management LLC increased its position in shares of CBIZ by 75.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 644 shares of the business services provider's stock worth $53,000 after purchasing an additional 276 shares during the last quarter. VisionPoint Advisory Group LLC bought a new position in CBIZ during the fourth quarter valued at approximately $60,000. Venturi Wealth Management LLC bought a new position in CBIZ during the fourth quarter valued at approximately $110,000. KBC Group NV grew its position in CBIZ by 30.1% during the fourth quarter. KBC Group NV now owns 2,021 shares of the business services provider's stock valued at $165,000 after acquiring an additional 468 shares during the last quarter. Finally, Huntington National Bank grew its position in CBIZ by 9.4% during the fourth quarter. Huntington National Bank now owns 2,220 shares of the business services provider's stock valued at $182,000 after acquiring an additional 191 shares during the last quarter. 87.44% of the stock is currently owned by institutional investors.

CBIZ Price Performance

NYSE CBZ traded down $1.91 on Thursday, reaching $72.39. 58,521 shares of the company's stock traded hands, compared to its average volume of 347,910. CBIZ, Inc. has a 12 month low of $62.66 and a 12 month high of $90.13. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a 50-day simple moving average of $73.47 and a 200 day simple moving average of $78.34. The stock has a market cap of $3.94 billion, a PE ratio of 30.67 and a beta of 0.91.

CBIZ (NYSE:CBZ - Get Free Report) last issued its earnings results on Thursday, April 24th. The business services provider reported $2.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.11 by $0.18. CBIZ had a net margin of 7.08% and a return on equity of 15.12%. The firm had revenue of $838.01 million for the quarter, compared to analysts' expectations of $860.25 million. During the same quarter last year, the business earned $1.54 earnings per share. The business's revenue was up 69.5% on a year-over-year basis. As a group, research analysts predict that CBIZ, Inc. will post 2.65 earnings per share for the current year.

Insider Transactions at CBIZ

In other news, Director Benaree Pratt Wiley sold 6,526 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $71.75, for a total value of $468,240.50. Following the transaction, the director now owns 41,759 shares in the company, valued at approximately $2,996,208.25. This trade represents a 13.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 4.95% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on CBZ. Wall Street Zen cut shares of CBIZ from a "hold" rating to a "sell" rating in a research report on Tuesday, February 25th. William Blair reiterated an "outperform" rating on shares of CBIZ in a research report on Friday, April 25th.

CBIZ Company Profile

CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.